Antiviral Activity of Resveratrol against Human and Animal Viruses

Advances in Virology

Volumn 2015, Issue , 2015, Pages

  Abba, Yusuf ^a,b   Hassim, Hasliza ^a   Hamzah, Hazilawati ^a   Noordin, Mohamed Mustapha ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MAIDUGURI   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949944754     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2015/184241     Document Type: Review

References (44)

1. K. B. Pandey and S. I. Rizvi, "Plant polyphenols as dietary antioxidants in human health and disease, " Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270-278, 2009.
2. S. Shankar, G. Singh, and R. K. Srivastava, "Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential, " Frontiers in Bioscience, vol. 12, no. 13, pp. 4839-4854, 2007.
3. I. Gülçin, "Antioxidant properties of resveratrol: a structureactivity insight, " Innovative Food Science and Emerging Technologies, vol. 11, no. 1, pp. 210-218, 2010.
4. M. Nakamura, H. Saito, M. Ikeda et al., "An antioxidant resveratrol significantly enhanced replication of hepatitis C virus, "World Journal of Gastroenterology, vol. 16, no. 2, pp. 184-192, 2010.
5. K. Cheng, Z. Wu, B. Gao, and J. Xu, "Analysis of influence of baicalin joint resveratrol retention enema on the TNF, SIgA, IL-2, IFN of rats with respiratory syncytial virus infection, " Cell Biochemistry and Biophysics, vol. 70, no. 2, pp. 1305-1309, 2014.
6. T. Liu, N. Zang, N. Zhou et al., "Resveratrol inhibits the TRIFdependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection, " Journal ofVirology, vol. 88, no. 8, pp. 4229-4236, 2014.
7. X.-H. Xie, N. Zang, S.-M. Li et al., "Resveratrol inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells, " Inflammation, vol. 35, no. 4, pp. 1392-1401, 2012.
8. N. Zang, S. Li, W. Li et al., "Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice, " International Immunopharmacology, vol. 28, no. 1, pp. 121-128, 2015.
9. N. Zang, X. Xie, Y. Deng et al., "Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice, " Journal of Virology, vol. 85, no. 24, pp. 13061-13068, 2011.
10. J. J. Docherty, T. J. Sweet, E. Bailey, S. A. Faith, and T. Booth, "Resveratrol inhibition of varicella-zoster virus replication in vitro, " Antiviral Research, vol. 72, no. 3, pp. 171-177, 2006.
11. J. L. Espinoza, A. Takami, L. Q. Trung, S. Kato, and S. Nakao, "Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells, " PLoS ONE, vol. 7, no. 12, Article ID e51306, 2012.
12. C.-Y. Yiu, S.-Y. Chen, L.-K. Chang, Y.-F. Chiu, and T.-P. Lin, "Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle, " Molecules, vol. 15, no. 10, pp. 7115-7124, 2010.
13. X. Chen, H. Qiao, T. Liu et al., "Inhibition of herpes simplex virus infection by oligomeric stilbenoids through ROS generation, " Antiviral Research, vol. 95, no. 1, pp. 30-36, 2012.
14. J. J. Docherty, M. M. Fu, J. M. Hah, T. J. Sweet, S. A. Faith, and T. Booth, "Effect of resveratrol on herpes simplex virus vaginal infection in the mouse, " Antiviral Research, vol. 67, no. 3, pp. 155-162, 2005.
15. J. J. Docherty, M. M. H. Fu, B. S. Stiffler, R. J. Limperos, C. M. Pokabla, and A. L. DeLucia, "Resveratrol inhibition of herpes simplex virus replication, " Antiviral Research, vol. 43, no. 3, pp. 145-155, 1999.
16. J. J. Docherty, J. S. Smith, M. M. Fu, T. Stoner, and T. Booth, "Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice, " Antiviral Research, vol. 61, no. 1, pp. 19-26, 2004.
17. C. L. Clouser, J. Chauhan, M. A. Bess et al., "Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine, " Bioorganic & Medicinal Chemistry Letters, vol. 22, no. 21, pp. 6642-6646, 2012.
18. A. Heredia, C. Davis, M. N. Amin et al., "Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabineresistant HIV-1, " AIDS, vol. 28, no. 3, pp. 317-323, 2014.
19. F. Sato, N. E. Martinez, M. Shahid, J. W. Rose, N. G. Carlson, and I. Tsunoda, "Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis, " The American Journal of Pathology, vol. 183, no. 5, pp. 1390-1396, 2013.
20. J. Gambini, M. Inglés, G. Olaso et al., "Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans, " Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 837042, 13 pages, 2015.
21. E. Wenzel and V. Somoza, "Metabolism and bioavailability of trans-resveratrol, "Molecular Nutrition & Food Research, vol. 49, no. 5, pp. 472-481, 2005.
22. T. Walle, "Bioavailability of resveratrol, " Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 9-15, 2011.
23. P. Vitaglione, S. Sforza, G. Galaverna et al., "Bioavailability of trans-resveratrol from red wine in humans, " Molecular Nutrition & Food Research, vol. 49, no. 5, pp. 495-504, 2005.
24. A. R. Neves, M. Lúcio, S. Martins, J. L. C. Lima, and S. Reis, "Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability, " International Journal of Nanomedicine, vol. 8, no. 1, pp. 177-187, 2013.
25. R. Penalva, I. Esparza, E. Larraneta, C. J. González-Navarro, C. Gamazo, and J. M. Irache, "Zein-Based nanoparticles improve the oral bioavailability of resveratrol and its anti-inflammatory effects in a mouse model of endotoxic shock, " Journal of Agricultural and Food Chemistry, vol. 63, no. 23, pp. 5603-5611, 2015.
26. J.-T. Hwang, D. Y. Kwon, O. J. Park, andM. S. Kim, "Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells, " Genes & Nutrition, vol. 2, no. 4, pp. 323-326, 2008.
27. S. M. Shin, I. J. Cho, and S. G. Kim, "Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3 inhibition downstream of poly (ADP-ribose) polymerase-LKB1 pathway, " Molecular Pharmacology, vol. 76, no. 4, pp. 884-895, 2009.
28. Y. Zheng, Y. Liu, J. Ge et al., "Resveratrol protects human lens epithelial cells against H2O2-induced oxidative stress by increasing catalase, SOD-1, and HO-1 expression, " Molecular Vision, vol. 16, pp. 1467-1474, 2010.
29. A. M. Posadino, A. Cossu, R. Giordo et al., "Resveratrol alters human endothelial cells redox state and causes mitochondrialdependent cell death, " Food and Chemical Toxicology, vol. 78, pp. 10-16, 2015.
30. A. T. Palamara, L. Nencioni, K. Aquilano et al., "Inhibition of influenzaAvirus replication by resveratrol, " Journal of Infectious Diseases, vol. 191, no. 10, pp. 1719-1729, 2005.
31. G. J. Kapadia, M. A. Azuine, H. Tokuda et al., "Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and themouse skin two-stage carcinogenesis, " Pharmacological Research, vol. 45, no. 6, pp. 499-505, 2002.
32. A. De Leo, G. Arena, E. Lacanna, G. Oliviero, F. Colavita, and E. Mattia, "Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets, " Antiviral Research, vol. 96, no. 2, pp. 196-202, 2012.
33. S. A. Faith, T. J. Sweet, E. Bailey, T. Booth, and J. J. Docherty, "Resveratrol suppresses nuclear factor-B in herpes simplex virus infected cells, " Antiviral Research, vol. 72, no. 3, pp. 242-251, 2006.
34. X. Long, S. Li, J. Xie et al., "MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-independent airway inflammation and AHR post RSV infection in nude mice, " Respiratory Research, vol. 16, no. 1, article 11, 2015.
35. L. Zhang, Y. Li, Z. Gu et al., "Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-B signaling pathway, " PLoS ONE, vol. 10, no. 2, Article IDe0116879, 2015.
36. J. Xu, Z. Yin, L. Li et al., "Inhibitory effect of resveratrol against duck enteritis virus in vitro, " PLoS ONE, vol. 8, no. 6, Article ID e65213, 2013.
37. N. Komaravelli, J. P. Kelley, M. P. Garofalo, H. Wu, A. Casola, and D. Kolli, "Role of dietary antioxidants in humanmetapneumovirus infection, " Virus Research, vol. 200, pp. 19-23, 2015.
38. I. Galindo, B. Hernáez, J. Berná et al., "Comparative inhibitory activity of the stilbenes resveratrol and oxyresveratrol on African swine fever virus replication, " Antiviral Research, vol. 91, no. 1, pp. 57-63, 2011.
39. P. Mastromarino, D. Capobianco, F. Cannata et al., "Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia, " Antiviral Research, vol. 123, pp. 15-21, 2015.
40. D. L. Evers, X. Wang, S.-M. Huong, D. Y. Huang, and E.-S. Huang, "3, 4, 5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling, " Antiviral Research, vol. 63, no. 2, pp. 85-95, 2004.
41. M. Campagna and C. Rivas, "Antiviral activity of resveratrol, " Biochemical Society Transactions, vol. 38, no. 1, pp. 50-53, 2010.
42. T. Yang, S. Li, X. Zhang, X. Pang, Q. Lin, and J. Cao, "Resveratrol, sirtuins, and viruses, " Reviews in Medical Virology, 2015.
43. E. Kaleta, "Herpesviruses of birds-a review, " Avian Pathology, vol. 19, no. 2, pp. 193-211, 2007.
44. R. U. Rani and B. Muruganandan, "Outbreak of duck viral enteritis in a vaccinated duck flock, " Scholars Journal of Agriculture and Veterinary Sciences B, vol. 2, no. 3, pp. 253-255, 2015.